TuHURA Biosciences (HURA) Profit After Tax (2010 - 2026)

TuHURA Biosciences' Profit After Tax history runs 17 years deep, the most recent figure standing at -$7.5 million for Q1 2026.

• On a quarterly basis, Profit After Tax fell 13.09% year-over-year to -$7.5 million in Q1 2026; TTM through Mar 2026 was -$30.9 million, a 19.58% increase from a year earlier, with the FY2025 full-year figure at -$30.1 million, down 38.6% from the prior year.
• Profit After Tax retreated to -$7.5 million in Q1 2026 per HURA's latest filing, from -$6.8 million in the prior quarter.
• Across five years, Profit After Tax topped out at $2.6 million in Q2 2023 and bottomed at -$15.7 million in Q3 2024.
• The 5-year median for Profit After Tax is -$6.0 million (2024), against an average of -$6.0 million.
• Across the five-year window, Profit After Tax slumped 493.9% in 2024 and soared 54.72% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$3.5 million in 2022, then declined by 15.37% to -$4.0 million in 2023, then slumped by 293.64% to -$15.7 million in 2024, then jumped by 56.9% to -$6.8 million in 2025, then fell by 11.47% to -$7.5 million in 2026.
• Per Business Quant, the three latest HURA Profit After Tax figures stand at -$7.5 million (Q1 2026), -$6.8 million (Q4 2025), and -$7.1 million (Q3 2025).